2,656 Shares in Teleflex Incorporated $TFX Purchased by Counterpoint Mutual Funds LLC

Key Points

• Counterpoint Mutual Funds LLC has acquired 2,656 shares of Teleflex Incorporated, valued at approximately $314,000, marking a new position for the firm.
• Insider purchases included a 1,500 share transaction by Director Jaewon Ryu, increasing their position by 67.36% to a total of 3,727 shares.
• Teleflex reported better than expected Q2 earnings of $3.73 per share, exceeding analysts' estimates of $3.36, along with a revenue of $780.90 million for the quarter.

Counterpoint Mutual Funds LLC acquired a new position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,656 shares of the medical technology company's stock, valued at approximately $314,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Teacher Retirement System of Texas acquired a new stake in Teleflex during the first quarter worth about $1,242,000. Amalgamated Bank increased its stake in shares of Teleflex by 56.9% in the first quarter. Amalgamated Bank now owns 14,046 shares of the medical technology company's stock valued at $1,941,000 after purchasing an additional 5,095 shares during the period. New York State Teachers Retirement System increased its stake in shares of Teleflex by 13.9% in the first quarter. New York State Teachers Retirement System now owns 45,063 shares of the medical technology company's stock valued at $6,227,000 after purchasing an additional 5,482 shares during the period. Brown Advisory Inc. increased its stake in shares of Teleflex by 34.2% in the first quarter. Brown Advisory Inc. now owns 2,524 shares of the medical technology company's stock valued at $349,000 after purchasing an additional 643 shares during the period. Finally, NorthCrest Asset Manangement LLC acquired a new stake in shares of Teleflex in the second quarter valued at approximately $299,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Insiders Place Their Bets

In other news, Director Jaewon Ryu bought 1,500 shares of the stock in a transaction that occurred on Tuesday, August 5th. The shares were acquired at an average cost of $115.00 per share, for a total transaction of $172,500.00. Following the purchase, the director owned 3,727 shares of the company's stock, valued at $428,605. This represents a 67.36% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Stuart A. Randle bought 1,000 shares of the stock in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average price of $115.86 per share, for a total transaction of $115,860.00. Following the completion of the purchase, the director directly owned 7,547 shares in the company, valued at $874,395.42. The trade was a 15.27% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 5,500 shares of company stock worth $633,590 in the last ninety days. 1.40% of the stock is owned by insiders.

Teleflex Stock Up 0.9%

Teleflex stock opened at $123.26 on Thursday. The company has a market capitalization of $5.45 billion, a P/E ratio of 29.00, a P/E/G ratio of 1.71 and a beta of 1.08. The firm's fifty day simple moving average is $122.17 and its 200-day simple moving average is $125.53. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, beating analysts' consensus estimates of $3.36 by $0.37. The business had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. Teleflex's revenue for the quarter was up 4.2% on a year-over-year basis. During the same quarter last year, the firm earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Friday, August 15th were paid a $0.34 dividend. The ex-dividend date was Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on TFX. Mizuho increased their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a report on Friday, August 1st. Wall Street Zen cut shares of Teleflex from a "strong-buy" rating to a "buy" rating in a report on Monday, September 15th. Royal Bank Of Canada upped their price target on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. Finally, Wells Fargo & Company cut their target price on shares of Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. One investment analyst has rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.